Click for best price
Intramuscular Drug Delivery Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Intramuscular Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intramuscular Drug Delivery. This report contains market size and forecasts of Intramuscular Drug Delivery in global, including the following market information:
Global Intramuscular Drug Delivery Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Intramuscular Drug Delivery market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Drug Molecule Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Intramuscular Drug Delivery include Antares Pharma, Eli Lily, Galaxo, HMD pharmaceuticals, Inovio Pharmaceuticals, Merck, Novartis, Pacira Pharmaceuticals and Pfizer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Intramuscular Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intramuscular Drug Delivery Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Intramuscular Drug Delivery Market Segment Percentages, by Type, 2022 (%)
Drug Molecule
Delivery Devices
Global Intramuscular Drug Delivery Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Intramuscular Drug Delivery Market Segment Percentages, by Application, 2022 (%)
Infectious Disease
Oncology
Autoimmune Diseases
Global Intramuscular Drug Delivery Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Intramuscular Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intramuscular Drug Delivery revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Intramuscular Drug Delivery revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Antares Pharma
Eli Lily
Galaxo
HMD pharmaceuticals
Inovio Pharmaceuticals
Merck
Novartis
Pacira Pharmaceuticals
Pfizer
Pharmajet
Teva Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Intramuscular Drug Delivery, market overview.
Chapter 2: Global Intramuscular Drug Delivery market size in revenue.
Chapter 3: Detailed analysis of Intramuscular Drug Delivery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Intramuscular Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Intramuscular Drug Delivery Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Intramuscular Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Intramuscular Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Intramuscular Drug Delivery Overall Market Size
2.1 Global Intramuscular Drug Delivery Market Size: 2022 VS 2030
2.2 Global Intramuscular Drug Delivery Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Intramuscular Drug Delivery Players in Global Market
3.2 Top Global Intramuscular Drug Delivery Companies Ranked by Revenue
3.3 Global Intramuscular Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Intramuscular Drug Delivery Companies in Global Market, by Revenue in 2022
3.5 Global Companies Intramuscular Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Intramuscular Drug Delivery Players in Global Market
3.6.1 List of Global Tier 1 Intramuscular Drug Delivery Companies
3.6.2 List of Global Tier 2 and Tier 3 Intramuscular Drug Delivery Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Intramuscular Drug Delivery Market Size Markets, 2022 & 2030
4.1.2 Drug Molecule
4.1.3 Delivery Devices
4.2 By Type - Global Intramuscular Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Intramuscular Drug Delivery Revenue, 2018-2023
4.2.2 By Type - Global Intramuscular Drug Delivery Revenue, 2024-2030
4.2.3 By Type - Global Intramuscular Drug Delivery Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Intramuscular Drug Delivery Market Size, 2022 & 2030
5.1.2 Infectious Disease
5.1.3 Oncology
5.1.4 Autoimmune Diseases
5.2 By Application - Global Intramuscular Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Intramuscular Drug Delivery Revenue, 2018-2023
5.2.2 By Application - Global Intramuscular Drug Delivery Revenue, 2024-2030
5.2.3 By Application - Global Intramuscular Drug Delivery Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Intramuscular Drug Delivery Market Size, 2022 & 2030
6.2 By Region - Global Intramuscular Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Intramuscular Drug Delivery Revenue, 2018-2023
6.2.2 By Region - Global Intramuscular Drug Delivery Revenue, 2024-2030
6.2.3 By Region - Global Intramuscular Drug Delivery Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Intramuscular Drug Delivery Revenue, 2018-2030
6.3.2 US Intramuscular Drug Delivery Market Size, 2018-2030
6.3.3 Canada Intramuscular Drug Delivery Market Size, 2018-2030
6.3.4 Mexico Intramuscular Drug Delivery Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Intramuscular Drug Delivery Revenue, 2018-2030
6.4.2 Germany Intramuscular Drug Delivery Market Size, 2018-2030
6.4.3 France Intramuscular Drug Delivery Market Size, 2018-2030
6.4.4 U.K. Intramuscular Drug Delivery Market Size, 2018-2030
6.4.5 Italy Intramuscular Drug Delivery Market Size, 2018-2030
6.4.6 Russia Intramuscular Drug Delivery Market Size, 2018-2030
6.4.7 Nordic Countries Intramuscular Drug Delivery Market Size, 2018-2030
6.4.8 Benelux Intramuscular Drug Delivery Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Intramuscular Drug Delivery Revenue, 2018-2030
6.5.2 China Intramuscular Drug Delivery Market Size, 2018-2030
6.5.3 Japan Intramuscular Drug Delivery Market Size, 2018-2030
6.5.4 South Korea Intramuscular Drug Delivery Market Size, 2018-2030
6.5.5 Southeast Asia Intramuscular Drug Delivery Market Size, 2018-2030
6.5.6 India Intramuscular Drug Delivery Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Intramuscular Drug Delivery Revenue, 2018-2030
6.6.2 Brazil Intramuscular Drug Delivery Market Size, 2018-2030
6.6.3 Argentina Intramuscular Drug Delivery Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Intramuscular Drug Delivery Revenue, 2018-2030
6.7.2 Turkey Intramuscular Drug Delivery Market Size, 2018-2030
6.7.3 Israel Intramuscular Drug Delivery Market Size, 2018-2030
6.7.4 Saudi Arabia Intramuscular Drug Delivery Market Size, 2018-2030
6.7.5 UAE Intramuscular Drug Delivery Market Size, 2018-2030
7 Intramuscular Drug Delivery Companies Profiles
7.1 Antares Pharma
7.1.1 Antares Pharma Company Summary
7.1.2 Antares Pharma Business Overview
7.1.3 Antares Pharma Intramuscular Drug Delivery Major Product Offerings
7.1.4 Antares Pharma Intramuscular Drug Delivery Revenue in Global Market (2018-2023)
7.1.5 Antares Pharma Key News & Latest Developments
7.2 Eli Lily
7.2.1 Eli Lily Company Summary
7.2.2 Eli Lily Business Overview
7.2.3 Eli Lily Intramuscular Drug Delivery Major Product Offerings
7.2.4 Eli Lily Intramuscular Drug Delivery Revenue in Global Market (2018-2023)
7.2.5 Eli Lily Key News & Latest Developments
7.3 Galaxo
7.3.1 Galaxo Company Summary
7.3.2 Galaxo Business Overview
7.3.3 Galaxo Intramuscular Drug Delivery Major Product Offerings
7.3.4 Galaxo Intramuscular Drug Delivery Revenue in Global Market (2018-2023)
7.3.5 Galaxo Key News & Latest Developments
7.4 HMD pharmaceuticals
7.4.1 HMD pharmaceuticals Company Summary
7.4.2 HMD pharmaceuticals Business Overview
7.4.3 HMD pharmaceuticals Intramuscular Drug Delivery Major Product Offerings
7.4.4 HMD pharmaceuticals Intramuscular Drug Delivery Revenue in Global Market (2018-2023)
7.4.5 HMD pharmaceuticals Key News & Latest Developments
7.5 Inovio Pharmaceuticals
7.5.1 Inovio Pharmaceuticals Company Summary
7.5.2 Inovio Pharmaceuticals Business Overview
7.5.3 Inovio Pharmaceuticals Intramuscular Drug Delivery Major Product Offerings
7.5.4 Inovio Pharmaceuticals Intramuscular Drug Delivery Revenue in Global Market (2018-2023)
7.5.5 Inovio Pharmaceuticals Key News & Latest Developments
7.6 Merck
7.6.1 Merck Company Summary
7.6.2 Merck Business Overview
7.6.3 Merck Intramuscular Drug Delivery Major Product Offerings
7.6.4 Merck Intramuscular Drug Delivery Revenue in Global Market (2018-2023)
7.6.5 Merck Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Intramuscular Drug Delivery Major Product Offerings
7.7.4 Novartis Intramuscular Drug Delivery Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 Pacira Pharmaceuticals
7.8.1 Pacira Pharmaceuticals Company Summary
7.8.2 Pacira Pharmaceuticals Business Overview
7.8.3 Pacira Pharmaceuticals Intramuscular Drug Delivery Major Product Offerings
7.8.4 Pacira Pharmaceuticals Intramuscular Drug Delivery Revenue in Global Market (2018-2023)
7.8.5 Pacira Pharmaceuticals Key News & Latest Developments
7.9 Pfizer
7.9.1 Pfizer Company Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Intramuscular Drug Delivery Major Product Offerings
7.9.4 Pfizer Intramuscular Drug Delivery Revenue in Global Market (2018-2023)
7.9.5 Pfizer Key News & Latest Developments
7.10 Pharmajet
7.10.1 Pharmajet Company Summary
7.10.2 Pharmajet Business Overview
7.10.3 Pharmajet Intramuscular Drug Delivery Major Product Offerings
7.10.4 Pharmajet Intramuscular Drug Delivery Revenue in Global Market (2018-2023)
7.10.5 Pharmajet Key News & Latest Developments
7.11 Teva Pharmaceutical
7.11.1 Teva Pharmaceutical Company Summary
7.11.2 Teva Pharmaceutical Business Overview
7.11.3 Teva Pharmaceutical Intramuscular Drug Delivery Major Product Offerings
7.11.4 Teva Pharmaceutical Intramuscular Drug Delivery Revenue in Global Market (2018-2023)
7.11.5 Teva Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Intramuscular Drug Delivery Market Opportunities & Trends in Global Market
Table 2. Intramuscular Drug Delivery Market Drivers in Global Market
Table 3. Intramuscular Drug Delivery Market Restraints in Global Market
Table 4. Key Players of Intramuscular Drug Delivery in Global Market
Table 5. Top Intramuscular Drug Delivery Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Intramuscular Drug Delivery Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Intramuscular Drug Delivery Revenue Share by Companies, 2018-2023
Table 8. Global Companies Intramuscular Drug Delivery Product Type
Table 9. List of Global Tier 1 Intramuscular Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Intramuscular Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Intramuscular Drug Delivery Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Intramuscular Drug Delivery Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Intramuscular Drug Delivery Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Intramuscular Drug Delivery Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Intramuscular Drug Delivery Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Intramuscular Drug Delivery Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Intramuscular Drug Delivery Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Intramuscular Drug Delivery Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Intramuscular Drug Delivery Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Intramuscular Drug Delivery Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Intramuscular Drug Delivery Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Intramuscular Drug Delivery Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Intramuscular Drug Delivery Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Intramuscular Drug Delivery Revenue, (US$, Mn), 2024-2030
Table 30. Antares Pharma Company Summary
Table 31. Antares Pharma Intramuscular Drug Delivery Product Offerings
Table 32. Antares Pharma Intramuscular Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 33. Antares Pharma Key News & Latest Developments
Table 34. Eli Lily Company Summary
Table 35. Eli Lily Intramuscular Drug Delivery Product Offerings
Table 36. Eli Lily Intramuscular Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 37. Eli Lily Key News & Latest Developments
Table 38. Galaxo Company Summary
Table 39. Galaxo Intramuscular Drug Delivery Product Offerings
Table 40. Galaxo Intramuscular Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 41. Galaxo Key News & Latest Developments
Table 42. HMD pharmaceuticals Company Summary
Table 43. HMD pharmaceuticals Intramuscular Drug Delivery Product Offerings
Table 44. HMD pharmaceuticals Intramuscular Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 45. HMD pharmaceuticals Key News & Latest Developments
Table 46. Inovio Pharmaceuticals Company Summary
Table 47. Inovio Pharmaceuticals Intramuscular Drug Delivery Product Offerings
Table 48. Inovio Pharmaceuticals Intramuscular Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 49. Inovio Pharmaceuticals Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Intramuscular Drug Delivery Product Offerings
Table 52. Merck Intramuscular Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Intramuscular Drug Delivery Product Offerings
Table 56. Novartis Intramuscular Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 57. Novartis Key News & Latest Developments
Table 58. Pacira Pharmaceuticals Company Summary
Table 59. Pacira Pharmaceuticals Intramuscular Drug Delivery Product Offerings
Table 60. Pacira Pharmaceuticals Intramuscular Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 61. Pacira Pharmaceuticals Key News & Latest Developments
Table 62. Pfizer Company Summary
Table 63. Pfizer Intramuscular Drug Delivery Product Offerings
Table 64. Pfizer Intramuscular Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 65. Pfizer Key News & Latest Developments
Table 66. Pharmajet Company Summary
Table 67. Pharmajet Intramuscular Drug Delivery Product Offerings
Table 68. Pharmajet Intramuscular Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 69. Pharmajet Key News & Latest Developments
Table 70. Teva Pharmaceutical Company Summary
Table 71. Teva Pharmaceutical Intramuscular Drug Delivery Product Offerings
Table 72. Teva Pharmaceutical Intramuscular Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 73. Teva Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Intramuscular Drug Delivery Segment by Type in 2022
Figure 2. Intramuscular Drug Delivery Segment by Application in 2022
Figure 3. Global Intramuscular Drug Delivery Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Intramuscular Drug Delivery Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Intramuscular Drug Delivery Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Intramuscular Drug Delivery Revenue in 2022
Figure 8. By Type - Global Intramuscular Drug Delivery Revenue Market Share, 2018-2030
Figure 9. By Application - Global Intramuscular Drug Delivery Revenue Market Share, 2018-2030
Figure 10. By Type - Global Intramuscular Drug Delivery Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Intramuscular Drug Delivery Revenue Market Share, 2018-2030
Figure 12. By Application - Global Intramuscular Drug Delivery Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Intramuscular Drug Delivery Revenue Market Share, 2018-2030
Figure 14. By Region - Global Intramuscular Drug Delivery Revenue Market Share, 2018-2030
Figure 15. By Country - North America Intramuscular Drug Delivery Revenue Market Share, 2018-2030
Figure 16. US Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Intramuscular Drug Delivery Revenue Market Share, 2018-2030
Figure 20. Germany Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 21. France Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Intramuscular Drug Delivery Revenue Market Share, 2018-2030
Figure 28. China Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 32. India Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Intramuscular Drug Delivery Revenue Market Share, 2018-2030
Figure 34. Brazil Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Intramuscular Drug Delivery Revenue Market Share, 2018-2030
Figure 37. Turkey Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Intramuscular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 41. Antares Pharma Intramuscular Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Eli Lily Intramuscular Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Galaxo Intramuscular Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. HMD pharmaceuticals Intramuscular Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Inovio Pharmaceuticals Intramuscular Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Merck Intramuscular Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novartis Intramuscular Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Pacira Pharmaceuticals Intramuscular Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pfizer Intramuscular Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Pharmajet Intramuscular Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Teva Pharmaceutical Intramuscular Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
